COMPASS Pathways Q3 2023 Results: Cash Injection To Sustain Phase 3 Psilocybin Program
VA Docs May Soon Recommend Medical Marijuana, Psychedelics Research: Bill Gets House Greenlight
Bipartisan Lawmakers Introduce Rescheduling Bill To Enable Psychedelics Research
Takeda's Narcolepsy Candidate Gets FDA Breakthrough Therapy Tag